Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO

BACKGROUND: Patients’ experience of symptoms often goes undetected during consultation in an outpatient clinic, and the use of a patient-reported outcome measure (PRO) in such a setting could be useful to aid treatment decision-making. A new PRO measure, the HM-PRO (Hematological Malignancy Specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Al-Obaidi, Magda J., Oblak, Metod, Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606444/
https://www.ncbi.nlm.nih.gov/pubmed/33192513
http://dx.doi.org/10.3389/fphar.2020.571066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606444/
https://www.ncbi.nlm.nih.gov/pubmed/33192513
http://dx.doi.org/10.3389/fphar.2020.571066

Ejemplares similares